High-dose dual therapy with a clavulanic acid component for Helicobacter pylori infection treatment: A Randomized Controlled Trial
This Paper With 6 Page And PDF Format Ready To Download
- Certificate
- I'm the author of the paper
Export:
Document National Code:
Index date: 2 November 2021
High-dose dual therapy with a clavulanic acid component for Helicobacter pylori infection treatment: A Randomized Controlled Trial abstract
High-dose dual therapy with a clavulanic acid component for Helicobacter pylori infection treatment: A Randomized Controlled Trial Keywords:
High-dose dual therapy with a clavulanic acid component for Helicobacter pylori infection treatment: A Randomized Controlled Trial authors
Department of internal medicine, Urmia University of Medical Science, Urmia, Iran.
Department of internal medicine, Gastroenterology and Hepatology section, Urmia University of Medical Science, Urmia, Iran.
Department of internal medicine, Gastroenterology and Hepatology section, Urmia University of Medical Science, Urmia, Iran.